Gulf International Bank (UK)’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-23,940
Closed -$1.08M 792
2021
Q1
$1.08M Sell
23,940
-9,460
-28% -$528K 0.01% 617
2020
Q4
$1.89M Buy
+33,400
New +$1.66M 0.02% 562
2015
Q4
Sell
-36,200
Closed -$1.46M 722
2015
Q3
$1.46M Hold
36,200
0.03% 605
2015
Q2
$2.08M Sell
36,200
-2,480
-6% -$158K 0.04% 542
2015
Q1
$2.46M Buy
+38,680
New +$2.62M 0.04% 468

Other funds holding IONS

Gulf International Bank (UK)'s IONS Position: Q2 2021 in Review

Gulf International Bank (UK) sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 23,940 shares — an estimated $1.08M sold.

Gulf International Bank (UK) first reported a position in IONS in Q1 2015 and held it in 5 quarters. The position peaked at $2.46M in Q1 2015. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

  • Gulf International Bank (UK) reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Gulf International Bank (UK) sold 23,940 Ionis Pharmaceuticals shares in Q2 2021, an estimated $1.08M.
  • Gulf International Bank (UK) first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 5 quarters.
  • Gulf International Bank (UK)'s Ionis Pharmaceuticals position peaked at $2.46M in Q1 2015.
  • 337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Gulf International Bank (UK)'s 13F filing for Q2 2021, filed 10 Aug 2021.